{"nct_id":"NCT03834519","title":"Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2019-05-02","start_date_type":"ACTUAL","primary_completion_date":"2022-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}